Chromos Plans to Restructure BURNABY, BC, April 12, 2007 - Chromos Molecular Systems Inc. today announced plans to make a restructuring proposal to the company's creditors and temporary employee ...
Chromos Molecular Systems, a small Canadian drug developer, says it is laying off about half of its 25 workers and is preparing to file for bankruptcy. In a statement released on Thursday, the company ...
Chromos Molecular Systems Inc. has announced that it has expanded the scope of its collaboration agreement with Pfizer. Under the expanded agreement, Chromos will use its ACE System to develop a cell ...
MUMBAI, July 19 (Reuters) - Drug maker Glenmark Pharmaceuticals Ltd. said on Thursday it bought two new biological entities from Canada's Chromos Molecular Systems Inc. to strengthen its biological ...
Chromos will engineer cell lines for Genitope Mab using its ACE system. Chromos Molecular Systems entered into a cell line engineering service agreement with Genitope to develop a cell line using ...
Chromos Molecular Systems of British Columbia has taken a license from Lonza Biologics, in the U.K., to use Lonza's proprietary CHOK1SV cell line with its own proprietary ACE System to produce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results